Global Dermal Fillers and Botulinum Toxin Market, By Type (Hyaluronic Acid-Based Fillers, Non-Hyaluronic Acid-Based Fillers, and Botulinum Toxin), By Application (Aesthetic Volume Restoration, Wrinkle Reduction), By End-User (Specialty & Dermatology Clinics, and Hospitals & Clinics), Forecast (2022-2028)

The global dermal fillers and botulinum toxin market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Dermal fillers and botulinum toxin are two of the most widely used therapeutic aesthetics and both therapies are popular due to providing quick, and visible results with minimal rest time. The increasing demand for slow-moving beauty products, increasing aging, and increasing skin diseases are the main factors driving the growth of the dermal fillers and botulinum toxin market.

According to the American Society of Plastic Surgeons, in 2020, approximately 4.4 million botulinum type procedures are performed in the US only. The rising number of such procedures is expected to drive the global dermal fillers and botulinum toxin market. Recent developments in the market is expected to drive the market growth.

For instance, in August 2021, Merz Therapeutics announced that it had received approval from the Russian Federal Service for Surveillance in Healthcare for the use of Xeomin, a neurotoxin (incobutlinumtoxinA) for the treatment of chronic sialorrhea due to neurodevelopmental disorders in children between 2 to 17 years of age.

Furthermore, in June 2021, the global leader in the production of botulinum toxin, Allergan PLC,  launched a campaign called ‘See for Yourself’, highlighting the success stories of real Botox cosmetic patients. The campaign was launched as part of an effort to reach audiences and consumers around the global.

 

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
  • By End-User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Allergan Inc., Galderma S.A., Suneva Medical, Merck & Co., Inc., Sanofi SA, and

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global DermalFillers and Botulinum Toxin  Market Report by Segment

By Type

• Hyaluronic Acid-Based Fillers
• Non-Hyaluronic Acid-Based Fillers
• Botulinum Toxin

By Application

• Aesthetic Volume Restoration
• Wrinkle Reduction

By End-Use

• Specialty & Dermatology Clinics
• Hospitals & Clinics

 

Global Dermal Fillers and Botulinum Toxin  Market Report by Region

North America

• US
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa